We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
CMC ICOS Biologics, a world-leading manufacturer of clinical and commercial therapeutic proteins, and Harpoon Therapeutics, an immunotherapeutic company, use its proprietary TriTAC ™ technology platform to discover and develop new biologics
CMC ICOS Biologics , the world's leading manufacturer of clinical and commercial therapeutic proteins, and immunology oncology firm Harpoon Therapeutics Inc. use its proprietary TriTAC ™ technology platform to discover and develop new biological agents